| Summary of Stock Options Outstanding under Plans |
The table below provides stock option information for the three months ended June 30, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares |
|
Weighted-
Average
Exercise
Price Per
Share |
|
Weighted-
Average
Remaining
Contractual
Life |
|
Aggregate
Intrinsic
Value of
In-the-
Money
Options |
|
|
|
|
|
|
|
|
(in thousands) |
|
Options outstanding at beginning of period |
386,901 |
|
|
$ |
17.53 |
|
|
6.5 years |
|
$ |
5,116 |
|
(1) |
Options exercised |
(10,500 |
) |
|
$ |
12.13 |
|
|
4.6 years |
|
— |
|
|
Options outstanding at end of period |
376,401 |
|
|
$ |
17.68 |
|
|
6.3 years |
|
$ |
4,168 |
|
(2) |
|
|
|
|
|
|
|
|
|
Options exercisable at end of period |
357,730 |
|
|
$ |
17.45 |
|
|
6.3 years |
|
$ |
4,042 |
|
(2) |
|
|
(1) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $30.75 as of March 31, 2017, over the exercise price, multiplied by the number of options.
|
|
|
(2) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $28.75 as of June 30, 2017, over the exercise price, multiplied by the number of options.
|
The table below provides stock option information for the six months ended June 30, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares |
|
Weighted-
Average
Exercise
Price Per
Share |
|
Weighted-
Average
Remaining
Contractual
Life |
|
Aggregate
Intrinsic
Value of
In-the-
Money
Options |
|
|
|
|
|
|
|
|
(in thousands) |
|
Options outstanding at beginning of period |
387,901 |
|
|
$ |
17.49 |
|
|
6.8 years |
|
$ |
6,752 |
|
(1) |
Options exercised |
(11,500 |
) |
|
$ |
12.16 |
|
|
4.7 years |
|
— |
|
|
Options outstanding at end of period |
376,401 |
|
|
$ |
17.68 |
|
|
6.3 years |
|
$ |
4,168 |
|
(2) |
|
|
|
|
|
|
|
|
|
Options exercisable at end of period |
357,730 |
|
|
$ |
17.45 |
|
|
6.3 years |
|
$ |
4,042 |
|
(2) |
|
|
(1) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $34.90 as of December 31, 2016, over the exercise price, multiplied by the number of options. |
|
|
(2) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $28.75 as of June 30, 2017, over the exercise price, multiplied by the number of options.
|
|
| Schedule of Restricted Stock Awards |
The table below provides information for restricted stock awards for the three and six months ended June 30, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, 2017 |
|
Six Months Ended
June 30, 2017 |
|
Number of
Shares |
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
Number of
Shares
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share
|
Restricted stock at beginning of period |
336,455 |
|
|
$ |
20.39 |
|
|
343,958 |
|
|
$ |
16.60 |
|
Restricted stock granted |
3,761 |
|
|
28.91 |
|
|
91,006 |
|
|
31.36 |
|
Restricted stock vested |
(30,430 |
) |
|
22.62 |
|
|
(119,344 |
) |
|
18.07 |
|
Restricted stock forfeited |
(3,835 |
) |
|
25.25 |
|
|
(9,669 |
) |
|
23.26 |
|
Restricted stock at end of period |
305,951 |
|
|
20.21 |
|
|
305,951 |
|
|
20.21 |
|
|